Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-17 5:06 PM View:  | Hawkins Richard J Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 24,363 | $11.18 | $272,378.00 | (100%) 24.36K to 0 | < 1% |
| 16-Oct-17 5:16 PM View: | Low Raymond Anthony VP, Finance & Controller Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 37,748 | $11.18 | $422,023.00 | (100%) 37.75K to 0 | |
| 16-Oct-17 5:17 PM View: | Blobel Friedhelm President, CEO, Director Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 387,299 | $11.18 | $4,330,000.00 | (100%) 387.3K to 0 | |
| 16-Oct-17 5:14 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 127,000 | $11.18 | $1,419,860.00 | (100%) 127.0K to 0 | |
| 16-Oct-17 5:12 PM View: | Chang Nancy T Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 70,000 | $11.18 | $782,600.00 | (100%) 70.0K to 0 | < 1% |
| 16-Oct-17 5:16 PM View: | Low Raymond Anthony VP, Finance & Controller Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Option Exercise | 11,250 | -- | -- | 42% 26.5K to 37.75K | |
| 16-Oct-17 5:17 PM View: | Blobel Friedhelm President, CEO, Director Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Option Exercise | 95,000 | -- | -- | 33% 292.3K to 387.3K | |
| 16-Oct-17 5:03 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Grant | 75,000 | -- | -- | 437% 17.16K to 92.16K | |
| 16-Oct-17 5:03 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Option Exercise | 52,000 | -- | -- | 56% 92.16K to 144.16K | |
| 16-Oct-17 5:07 PM View: | Chern Carey General Counsel | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Payment of Exercise | 11,274 | $11.18 | $126,043.00 | (100%) 11.27K to 0 | |
| 16-Oct-17 5:16 PM View: | Saxe Jon S Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 135,000 | $11.18 | $1,509,300.00 | (100%) 135.0K to 0 | < 1% |
| 16-Oct-17 5:07 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 8,000 | $11.18 | $89,440.00 | (100%) 8.0K to 0 | |
| 16-Oct-17 5:17 PM View: | Blobel Friedhelm President, CEO, Director Director | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Grant | 150,000 | -- | -- | 105% 142.3K to 292.3K | |
| 16-Oct-17 5:03 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Disposition | 144,158 | $11.18 | $1,611,690.00 | (100%) 144.16K to 0 | |
| 16-Oct-17 5:07 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Option Exercise | 8,000 | -- | -- | 100% 0 to 8.0K | |
| 16-Oct-17 5:14 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 16-Oct-17 5:14 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 13-Oct-17 | Option Exercise | 52,000 | -- | -- | 69% 75.0K to 127.0K | |
| 16-Aug-17 8:05 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 16-Aug-17 | Market Option Sale | 10,000 | $11.00 | $110,000.00 | (100%) 10.0K to 0 | |
| 16-Aug-17 8:07 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 16-Aug-17 | Market Option Sale | 30,000 | $11.00 | $330,000.00 | (100%) 30.0K to 0 | |
| 16-Aug-17 5:52 PM View: | Low Raymond Anthony VP, Finance & Controller | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Option Exercise | 10,000 | -- | -- | 64% 15.54K to 25.54K | |
| 16-Aug-17 5:55 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Option Exercise | 30,000 | -- | -- | 1603% 1.87K to 31.87K | |
| 16-Aug-17 8:05 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Option Exercise | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 16-Aug-17 5:55 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Payment of Exercise | 14,714 | $11.05 | $162,590.00 | (46%) 31.87K to 17.16K | |
| 16-Aug-17 8:07 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 16-Aug-17 8:02 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Payment of Exercise | 20,872 | $11.05 | $230,636.00 | (13%) 162.21K to 141.34K | |
| 16-Aug-17 8:02 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 15-Aug-17 | Option Exercise | 40,000 | -- | -- | 33% 122.21K to 162.21K | |
| 03-Jul-17 4:02 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 30-Jun-17 | Option Exercise | 35,044 | $3.88 | $136,082.00 | 29% 122.21K to 157.25K | |
| 03-Jul-17 4:02 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 30-Jun-17 | Market Option Sale (Planned) | 35,044 | $11.00 | $385,484.00 | (22%) 157.25K to 122.21K | |
| 22-Jun-17 4:14 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 20-Jun-17 | Option Exercise | 70,000 | $3.55 | $248,500.00 | 57% 122.21K to 192.21K | |
| 22-Jun-17 4:14 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 20-Jun-17 | Market Option Sale (Planned) | 70,000 | $10.91 | $763,627.00 | (36%) 192.21K to 122.21K | |
| 14-Jun-17 4:48 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Market Option Sale | 40,500 | $10.75 | $435,375.00 | (100%) 40.5K to 0 | |
| 14-Jun-17 4:55 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Market Option Sale | 40,500 | $10.75 | $435,375.00 | (96%) 42.37K to 1.87K | |
| 14-Jun-17 4:50 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Option Exercise | 1,000 | -- | -- | 100% 0 to 1.0K | |
| 14-Jun-17 4:48 PM View: | Zhao Hong CEO, China Operations | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Option Exercise | 40,500 | -- | -- | 100% 0 to 40.5K | |
| 14-Jun-17 6:08 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Payment of Exercise | 26,090 | $10.75 | $280,468.00 | (18%) 148.3K to 122.21K | |
| 14-Jun-17 4:53 PM View: | Low Raymond Anthony VP, Finance & Controller | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Option Exercise | 1,250 | -- | -- | 9% 14.29K to 15.54K | |
| 14-Jun-17 4:50 PM View: | Xie Lan VP Finance, China CFO | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Market Option Sale | 1,000 | $10.75 | $10,750.00 | (100%) 1.0K to 0 | |
| 14-Jun-17 6:08 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Option Exercise | 55,000 | -- | -- | 59% 93.3K to 148.3K | |
| 14-Jun-17 4:55 PM View: | Cheung Wilson Wai-Shun CFO & Senior VP, Finance | SciClone Pharmaceuticals, I... (SCLN) | 12-Jun-17 | Option Exercise | 40,500 | -- | -- | 2163% 1.87K to 42.37K | |
| 09-Jun-17 5:39 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 08-Jun-17 | Option Exercise | 19,956 | $3.55 | $70,843.80 | 21% 93.3K to 113.25K | |
| 09-Jun-17 5:39 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 08-Jun-17 | Market Option Sale (Planned) | 19,956 | $11.00 | $219,608.00 | (18%) 113.25K to 93.3K | |
| 09-Jun-17 5:39 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 07-Jun-17 | Option Exercise | 19,700 | $3.55 | $69,935.00 | 21% 93.3K to 113.0K | |
| 09-Jun-17 5:39 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 07-Jun-17 | Market Option Sale (Planned) | 19,700 | $10.03 | $197,524.00 | (17%) 113.0K to 93.3K | |
| 06-Jun-17 6:37 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 06-Jun-17 | Planned Private Option Sale | 5,500 | $10.00 | $55,000.00 | (6%) 98.8K to 93.3K | |
| 06-Jun-17 6:37 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 06-Jun-17 | Option Exercise | 5,500 | $3.55 | $19,525.00 | 6% 93.3K to 98.8K | |
| 06-Jun-17 6:37 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 02-Jun-17 | Option Exercise | 4,800 | $3.55 | $17,040.00 | 5% 93.3K to 98.1K | |
| 06-Jun-17 6:37 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 02-Jun-17 | Planned Private Option Sale | 4,800 | $10.00 | $48,000.00 | (5%) 98.1K to 93.3K | |
| 25-May-17 4:22 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 24-May-17 | Option Exercise | 6,298 | $3.55 | $22,357.90 | 7% 92.53K to 98.82K | |
| 25-May-17 4:22 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 24-May-17 | Market Option Sale (Planned) | 6,298 | $9.36 | $58,975.10 | (6%) 98.82K to 92.53K | |
| 25-May-17 4:22 PM View: | Blobel Friedhelm President & CEO Director | SciClone Pharmaceuticals, I... (SCLN) | 23-May-17 | Market Option Sale (Planned) | 15,166 | $9.31 | $141,154.00 | (14%) 107.69K to 92.53K |
